Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
ID: 350334Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (R01 Clinical Trial Not Allowed). This initiative aims to support interdisciplinary research that enhances understanding of how genetic and non-genetic factors influence complex trait variations across individuals and populations, emphasizing the use of formal theories and large-scale datasets. The opportunity is significant for advancing knowledge in human genetic diversity and health disparities, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. Applications will be accepted starting January 5, 2024, with deadlines extending until January 8, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announced a funding opportunity titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (R01 Clinical Trial Not Allowed). The initiative seeks to advance applications that develop interdisciplinary methods to better comprehend how genetic and non-genetic factors contribute to variations in complex traits across populations. Proposals should incorporate a holistic understanding of these interactions, utilizing formal theories and large-scale datasets. Key details include the open application date of January 5, 2024, with subsequent deadlines throughout the year until January 8, 2027. Eligible applicants range from academic institutions to nonprofit organizations, and proposals should emphasize collaborative, diverse team compositions. Applicants must submit a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity within research. The selection process involves stringent criteria, including the project's significance, innovation, approach, and the research environment. This funding opportunity highlights NIH's commitment to understanding human genetic diversity and health disparities, requiring applicants to demonstrate rigorous methodologies and utilize data responsibly while addressing socially sensitive issues. The initiative is designed to generate impactful research capable of improving health outcomes through innovative and responsible genetic studies.
    Similar Opportunities
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Exploratory/Developmental Research Grant to develop novel theories and methodologies for understanding the genetic architecture of complex human traits. The objective is to support innovative research that explores both genetic and non-genetic factors influencing trait variation across biological, social, and ecological levels, with a particular emphasis on addressing cancer disparities and employing systems epidemiology modeling. This grant allows for a budget of up to $275,000 over a two-year period, and applications are open to a diverse range of organizations, including higher education institutions and nonprofits. Interested applicants can find more information and submit their proposals by the close date of January 7, 2027, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a Notice of Funding Opportunity (NOFO) titled "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II" (PAR-24-241), aimed at establishing a Coordinating Center to enhance psychiatric genetic studies in diverse populations. This initiative seeks to address the underrepresentation of genetic data from non-European ancestries in mental health research, promoting data harmonization, joint analyses, and ethical practices while fostering collaboration among various research projects. Eligible applicants include higher education institutions, non-profits, tribal governments, and other organizations, with the application period opening on September 11, 2024, and a maximum award period of five years. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-241.html.
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)" aimed at enhancing the understanding of psychiatric disorders in diverse populations, particularly those of African ancestry. This initiative seeks applications for cooperative agreements that will focus on accelerating gene discovery efforts and promoting global mental health equity, addressing the existing gap in genomic studies that predominantly center on European populations. The funding is intended to support innovative research approaches that incorporate community engagement and career development for underrepresented groups, with a project period of up to five years. Interested applicants can find more details and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with the application deadline set for February 13, 2026.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting research proposals focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative aims to encourage multidisciplinary research that explores various methods to address emerging ELSI questions, particularly in relation to health disparities and the implications of genomic data sharing. The NIH emphasizes the importance of including diverse perspectives in research, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application, which will be evaluated during the review process. Interested applicants, including higher education institutions and community-based organizations, can submit proposals starting January 19, 2024, with a closing date for applications set for November 18, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)" aimed at enhancing workforce diversity in genomics research. This initiative seeks to support educational programs that provide research experiences and skills development for individuals from diverse and underrepresented backgrounds, particularly targeting undergraduate and post-baccalaureate trainees. The program emphasizes the importance of mentorship and innovative educational strategies to foster a diverse research community, ultimately driving advancements in biomedical sciences and improving health equity. Interested applicants can find more information and submit proposals through Grants.gov, with a funding ceiling of $325,000 and a submission deadline of January 27, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.